Phase II Study of Oxaliplatin in Patients With Unresectable, Metastatic, or Recurrent Hepatocellular Cancer

Authors

Keywords

Journal

Volume 31, Issue 4, Pages 317-322

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2009-03-06

DOI

10.1097/coc.0b013e318162f57d

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now